Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Outlook Therapeutics (OTLK) over the last 7 years, with Q2 2025 value amounting to 0.91.

  • Outlook Therapeutics' Debt Ratio changed N/A to 0.91 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.91, marking a year-over-year change of. This contributed to the annual value of 0.39 for FY2019, which is 522059.21% up from last year.
  • As of Q2 2025, Outlook Therapeutics' Debt Ratio stood at 0.91.
  • Outlook Therapeutics' 5-year Debt Ratio high stood at 1.1 for Q1 2025, and its period low was 0.91 during Q2 2025.